Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33637) 33637
Newspaper Article (5207) 5207
Newsletter (807) 807
Magazine Article (559) 559
Book Chapter (480) 480
Web Resource (69) 69
Trade Publication Article (58) 58
Book / eBook (39) 39
Dissertation (29) 29
Paper (19) 19
Reference (16) 16
Publication (15) 15
Government Document (14) 14
Conference Proceeding (10) 10
Book Review (5) 5
Report (3) 3
Transcript (3) 3
Journal / eJournal (2) 2
Library Holding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24169) 24169
diarrhea (22359) 22359
science & technology (18156) 18156
life sciences & biomedicine (17322) 17322
male (12902) 12902
female (12605) 12605
adult (7711) 7711
middle aged (7082) 7082
biological and medical sciences (6039) 6039
infant (5995) 5995
medical sciences (5678) 5678
aged (5335) 5335
diarrhea - etiology (5189) 5189
animals (4740) 4740
diarrhea - drug therapy (4710) 4710
child, preschool (4699) 4699
patients (4371) 4371
abridged index medicus (4176) 4176
child (4000) 4000
infectious diseases (3785) 3785
diarrhea - chemically induced (3705) 3705
diarrhea - therapy (3700) 3700
infections (3346) 3346
treatment outcome (3336) 3336
oncology (3289) 3289
antibiotics (3188) 3188
clinical trials (3137) 3137
care and treatment (3016) 3016
pediatrics (2910) 2910
health aspects (2895) 2895
research (2881) 2881
adolescent (2712) 2712
gastroenterology & hepatology (2666) 2666
diarrhea - microbiology (2603) 2603
risk factors (2368) 2368
drug therapy (2358) 2358
pain (2341) 2341
chemotherapy (2181) 2181
general & internal medicine (2111) 2111
infant, newborn (2036) 2036
microbiology (2029) 2029
medicine, general & internal (2025) 2025
children (2009) 2009
pharmacology & pharmacy (1984) 1984
anti-bacterial agents - therapeutic use (1983) 1983
irritable bowel syndrome (1968) 1968
pharmacology. drug treatments (1945) 1945
analysis (1939) 1939
studies (1934) 1934
inflammatory bowel disease (1929) 1929
diarrhea - epidemiology (1928) 1928
cancer (1916) 1916
drug dosages (1882) 1882
constipation (1831) 1831
vomiting (1824) 1824
medical research (1808) 1808
medicine (1801) 1801
acute disease (1752) 1752
cancer therapies (1750) 1750
mortality (1740) 1740
immunology (1713) 1713
aged, 80 and over (1706) 1706
research article (1704) 1704
abdomen (1676) 1676
fluid therapy (1639) 1639
bacteria (1619) 1619
metastasis (1562) 1562
diarrhea - prevention & control (1538) 1538
diarrhoea (1505) 1505
nausea (1490) 1490
fda approval (1467) 1467
tumors (1440) 1440
pharmaceutical industry (1389) 1389
intestine (1387) 1387
diarrhea - diagnosis (1338) 1338
prospective studies (1337) 1337
retrospective studies (1335) 1335
epidemiology (1331) 1331
feces - microbiology (1330) 1330
medicine & public health (1325) 1325
diagnosis (1320) 1320
gastroenterology. liver. pancreas. abdomen (1318) 1318
hospitals (1301) 1301
probiotics (1294) 1294
clostridium difficile (1276) 1276
double-blind method (1258) 1258
public, environmental & occupational health (1258) 1258
young adult (1247) 1247
laboratories (1232) 1232
diarrhea - complications (1231) 1231
gastroenterology (1227) 1227
diarrhea, infantile - therapy (1222) 1222
administration, oral (1184) 1184
time factors (1174) 1174
pneumonia (1168) 1168
chronic disease (1167) 1167
medicine, experimental (1128) 1128
diagnosis, differential (1115) 1115
neutropenia (1086) 1086
public health (1074) 1074
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (26) 26
Online Resources - Online (10) 10
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Providence Healthcare - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37763) 37763
German (869) 869
French (803) 803
Spanish (621) 621
Japanese (280) 280
Chinese (256) 256
Portuguese (237) 237
Russian (199) 199
Italian (196) 196
Polish (136) 136
Dutch (96) 96
Danish (45) 45
Swedish (45) 45
Czech (37) 37
Romanian (33) 33
Norwegian (32) 32
Turkish (31) 31
Hungarian (28) 28
Hebrew (26) 26
Korean (20) 20
Finnish (16) 16
Croatian (11) 11
Slovak (9) 9
Serbian (8) 8
Ukrainian (7) 7
Bulgarian (4) 4
Persian (4) 4
Indonesian (3) 3
Urdu (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Icelandic (2) 2
Lithuanian (2) 2
Latin (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Management of toxicities of immune checkpoint inhibitors
by Spain, Lavinia and Diem, Stefan and Larkin, James
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Advances in prevention and therapy of neonatal dairy calf diarrhoea: A systematical review with emphasis on colostrum management and fluid therapy
by Meganck, Vanessa and Hoflack, Geert and Opsomer, Geert
Acta veterinaria scandinavica, ISSN 0044-605X, 2014, Volume 56, Issue 1, pp. 75 - 75
Fluid therapy | Neonatal calf diarrhoea | Colostrum management | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Animals, Newborn | Cattle Diseases - prevention & control | Fluid Therapy - veterinary | Animals | Diarrhea - therapy | Cattle | Cattle Diseases - therapy | Diarrhea - etiology | Diarrhea - prevention & control | Diarrhea - veterinary | Colostrum - physiology | Cattle Diseases - etiology | Infants (Newborn) | Care and treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Fecal Microbiota Transplantation — An Old Therapy Comes of Age
by Kelly, Ciarán P
The New England journal of medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 5, pp. 474 - 475
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Diarrhea - therapy | Vancomycin - therapeutic use | Humans | Clostridium difficile | Female | Male | Care and treatment | Usage | Clostridium infections | Patient outcomes | Dosage and administration | Vancomycin | Drug therapy | Health aspects | Infusion therapy | Microbiota | Antibiotics | Fecal microflora | Intestine | Mortality | Infections | Transplantation | Intestinal microflora | Feces | Enterocolitis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
by Aboud, Michael and Kaplan, Richard and Lombaard, Johannes and Zhang, Fujie and Hidalgo, José A and Mamedova, Elmira and Losso, Marcelo H and Chetchotisakd, Ploenchan and Brites, Carlos and Sievers, Jörg and Brown, Dannae and Hopking, Judy and Underwood, Mark and Nascimento, Maria Claudia and Punekar, Yogesh and Gartland, Martin and Smith, Kimberly
The Lancet infectious diseases, ISSN 1473-3099, 03/2019, Volume 19, Issue 3, pp. 253 - 264
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Salvage Therapy - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Treatment Outcome | Viral Load | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Anti-HIV Agents - administration & dosage | Young Adult | HIV-1 - isolation & purification | Adolescent | Adult | Female | HIV Infections - drug therapy | Aged | Sustained Virologic Response | Antiretroviral Therapy, Highly Active - methods | Salvage Therapy - methods | Highly active antiretroviral therapy | Analysis | Lopinavir | DNA polymerases | Nucleosides | Adults | Product development | HIV (Viruses) | Health aspects | Health care | Slopes | Drugs | Therapy | RNA-directed DNA polymerase | Gastrointestinal tract diseases | Ritonavir | Clinical trials | Infections | Drug resistance | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Safety | Drug therapy | Active control | Failure | Public health | Antiretroviral drugs | Anemia | Diarrhea | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | Studies | Lower bounds | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Algorithms | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
by Burger, Jan A and Tedeschi, Alessandra and Barr, Paul M and Robak, Tadeusz and Owen, Carolyn and Ghia, Paolo and Bairey, Osnat and Hillmen, Peter and Bartlett, Nancy L and Li, Jianyong and Simpson, David and Grosicki, Sebastian and Devereux, Stephen and McCarthy, Helen and Coutre, Steven and Quach, Hang and Gaidano, Gianluca and Maslyak, Zvenyslava and Stevens, Don A and Janssens, Ann and Offner, Fritz and Mayer, Jiří and O’Dwyer, Michael and Hellmann, Andrzej and Schuh, Anna and Siddiqi, Tanya and Polliack, Aaron and Tam, Constantine S and Suri, Deepali and Cheng, Mei and Clow, Fong and Styles, Lori and James, Danelle F and Kipps, Thomas J and RESONATE-2 Investigators
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Chlorambucil - adverse effects | Chlorambucil - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Disease-Free Survival | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neutropenia - chemically induced | Pyrazoles - adverse effects | Clinical trials | Treatment outcome | Usage | Lymphocytic leukemia | Drug therapy | Analysis | Chronic lymphatic leukemia | Leukemia | Diarrhea | Fatigue | Nausea | Lymphatic leukemia | Lymphoma | Hemorrhage | Survival | Cough | Chlorambucil | Immunosuppression | Chemotherapy | Vomiting | Immunotherapy | Hemoglobin | Myelosuppression | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
by Sharma, Padmanee, Prof and Retz, Margitta, Prof and Siefker-Radtke, Arlene, MD and Baron, Ari, MD and Necchi, Andrea, MD and Bedke, Jens, Prof and Plimack, Elizabeth R, MD and Vaena, Daniel, MD and Grimm, Marc-Oliver, Prof and Bracarda, Sergio, MD and Arranz, José Ángel, MD and Pal, Sumanta, MD and Ohyama, Chikara, Prof and Saci, Abdel, PhD and Qu, Xiaotao, PhD and Lambert, Alexandre, PhD and Krishnan, Suba, MD and Azrilevich, Alex, PharmD and Galsky, Matthew D, Prof
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 312 - 322
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Carcinoma, Transitional Cell - drug therapy | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Platinum - pharmacology | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Chemotherapy | Carcinoma | Immunoglobulin G | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Care and treatment | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders
by Chayama, Kazuaki and Takahashi, Shoichi and Toyota, Joji and Karino, Yoshiyasu and Ikeda, Kenji and Ishikawa, Hiroki and Watanabe, Hideaki and McPhee, Fiona and Hughes, Eric and Kumada, Hiromitsu
Hepatology (Baltimore, Md.), ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 742 - 748
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Antiviral agents | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recombinant Proteins - therapeutic use | Isoquinolines - adverse effects | Hepatitis C - drug therapy | Humans | Middle Aged | Hepacivirus - genetics | Diarrhea - epidemiology | Male | Diarrhea - chemically induced | Polyethylene Glycols - therapeutic use | Incidence | Hepatitis C - ethnology | Treatment Failure | Protease Inhibitors - adverse effects | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Headache - chemically induced | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Japan | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Headache - epidemiology | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Aged | Viral Nonstructural Proteins - antagonists & inhibitors | Proteins | Hepatitis | Genotype & phenotype | Interferon | Infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Systematic review: colitis associated with anti‐CTLA‐4 therapy
by Gupta, A and De Felice, K. M and Loftus, E. V and Khanna, S
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 08/2015, Volume 42, Issue 4, pp. 406 - 417
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Immunotherapy - methods | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Colitis - chemically induced | Melanoma - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Algorithms | Corticosteroids | Colitis | T cells | Immunotherapy | Melanoma | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights